ACADIAN ASSET MANAGEMENT LLC - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 89 filers reported holding HARPOON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$53
-36.9%
76,710
-32.5%
0.00%
Q1 2023$84
-7.7%
113,702
-10.4%
0.00%
Q4 2022$91
-99.8%
126,954
+124.2%
0.00%
Q3 2022$54,000
-50.5%
56,6350.0%0.00%
-100.0%
Q2 2022$109,000
-65.7%
56,635
+147.0%
0.00%0.0%
Q2 2021$318,000
-69.0%
22,933
-53.3%
0.00%
-75.0%
Q1 2021$1,026,000
+71.6%
49,066
+36.4%
0.00%
+100.0%
Q4 2020$598,000
+79.0%
35,968
+82.6%
0.00%
+100.0%
Q3 2020$334,000
-10.9%
19,702
-12.8%
0.00%
-50.0%
Q2 2020$375,000
+316.7%
22,595
+189.5%
0.00%
+100.0%
Q1 2020$90,0007,8060.00%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 3,156,699$15,689,0007.73%
MPM ASSET MANAGEMENT LLC 3,131,388$15,563,0005.32%
MPM BioImpact LLC 3,196,707$15,888,0004.26%
ACUTA CAPITAL PARTNERS, LLC 497,500$2,473,0001.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 151,445$2,771,0000.62%
Orbimed Advisors 3,039,508$15,106,0000.24%
Artal Group S.A. 1,000,000$4,970,0000.21%
Cormorant Asset Management, LP 540,600$2,687,0000.21%
DAFNA Capital Management LLC 105,163$523,0000.14%
Ikarian Capital, LLC 117,009$582,0000.08%
View complete list of HARPOON THERAPEUTICS INC shareholders